By Dr. John Bachynsky
Drug prices are excessive. (Patented Medicine Prices Review Board says NO)
Drug prices are among the highest cost drivers in health care.
Provincial drug programs cannot afford new drugs.
Old drugs are as good as new drugs.
You can’t trust big pharma.
You can trust government.
Drugs are not safe.
A lot of cheap drugs provide good therapy.
Generic drugs are exactly the same as brand name drugs.
Poor prescribing is the fault of the drug industry and not physicians.
Health Canada regulations make drugs safer and improve health care.
The best way to deal with drug shortages is to create a web site that lists the shortages.
Bulk purchasing will save billions and have no adverse effect on the pharmaceutical system.
Adding and deleting drugs from a benefit list improves drug use and prescribing.
Drugs can only be evaluated by randomized clinical trials.
Canada has one of the best pharmaceutical systems in the world.
Specialists who do drug trials cannot be trusted on drug benefit committees.
Health economists are important in operating a drug benefit program but not ethicists.
Common Drug Review (CDR) recommendations can be applied to a geriatric population.
Dr. John Bachynsky is Professor Emeritus at the University of Alberta and a Patient Advocate at The Cameron Institute.